Neogenomics (NEO) Other Non-Current Liabilities (2017 - 2026)

Neogenomics (NEO) has 10 years of Other Non-Current Liabilities data on file, last reported at $862000.0 in Q2 2026.

• Quarterly Other Non-Current Liabilities fell 92.88% year-over-year to $862000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $862000.0 (down 92.88% YoY) and the FY2025 annual result came in at $12.0 million, up 2.29% from the prior year.
• Other Non-Current Liabilities retreated to $862000.0 in Q2 2026, from $12.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $14.2 million in Q3 2022 to a low of $862000.0 in Q2 2026.
• A 5-year average of $12.0 million and a median of $12.6 million in 2024 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 281.47% — and 2026, when it sank 92.88%.
• Tracing NEO's Other Non-Current Liabilities over 5 years: stood at $13.1 million in 2022, then decreased by 0.16% to $13.0 million in 2023, then declined by 9.68% to $11.8 million in 2024, then advanced by 2.29% to $12.0 million in 2025, then sank by 92.84% to $862000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $862000.0 (Q2 2026), $12.0 million (Q1 2026), and $12.0 million (Q4 2025), per Business Quant data.